Antecip BioVentures II LLC

General

Total Cases16

Active Cases1

Patents249

CourtsD. New Jersey

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

L5

E

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
02/11/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	STIPULATION AND ORDER OF DISMISSAL without prejudice, and without costs or attorneys' fees to any party. Signed by Judge Michael E. Farbiarz on 2/11/2025. (wh) (Entered: 02/11/2025)
02/10/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	Letter from Plaintiffs to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 02/10/2025)
01/16/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	AMENDED SCHEDULING ORDER. Signed by Magistrate Judge Leda D. Wettre on 1/15/2025. (wh) (Entered: 01/16/2025)
01/15/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-06489 ( D. NJ )	AMENDED SCHEDULING ORDER. Signed by Magistrate Judge Leda D. Wettre on 1/15/2025. (wh) (Entered: 01/15/2025)
01/13/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	Letter from Plaintiffs to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 01/13/2025)
01/13/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-06489 ( D. NJ )	Letter from Plaintiffs to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 01/13/2025)
01/08/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-06489 ( D. NJ )	ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-06489 and 24-10938 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-06489 and that Civil Action No. 24-10938 shall be administratively terminated by the Clerk's Office. To accommodate Plaintiffs' assertion of the '889 patent, the parties shall abide by the herein schedule. The December 5 Pretrial Schedule Order shall otherwise govern the Consolidated Actions (ECF No. [27] in 24-06489). Signed by Magistrate Judge Leda D. Wettre on 1/7/2025. (wh) (Entered: 01/08/2025) ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-06489 and 24-10938 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-06489 and that Civil Action No. 24-10938 shall be administratively terminated by the Clerk's Office. To accommodate Plaintiffs' assertion of the '889 patent, the parties shall abide by the herein schedule. The December 5 Pretrial Schedule Order shall otherwise govern the Consolidated Actions (ECF No. [27] in 24-06489). Signed by Magistrate Judge Leda D. Wettre on 1/7/2025. (wh) (Entered: 01/08/2025)
01/08/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-10938 ( D. NJ )	ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-06489 and 24-10938 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-06489 and that Civil Action No. 24-10938 shall be administratively terminated by the Clerk's Office. To accommodate Plaintiffs' assertion of the '889 patent, the parties shall abide by the herein schedule. The December 5 Pretrial Schedule Order shall otherwise govern the Consolidated Actions (ECF No. 27 in 24-06489). Signed by Magistrate Judge Leda D. Wettre on 1/7/2025. (wh) (Entered: 01/08/2025) ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-06489 and 24-10938 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-06489 and that Civil Action No. 24-10938 shall be administratively terminated by the Clerk's Office. To accommodate Plaintiffs' assertion of the '889 patent, the parties shall abide by the herein schedule. The December 5 Pretrial Schedule Order shall otherwise govern the Consolidated Actions (ECF No. 27 in 24-06489). Signed by Magistrate Judge Leda D. Wettre on 1/7/2025. (wh) (Entered: 01/08/2025)
01/08/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-10938 ( D. NJ )	***Civil Case Terminated pursuant to [12] ORDER CONSOLIDATING CASES FOR ALL PURPOSES. (wh) (Entered: 01/08/2025)
01/06/25	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-06489 ( D. NJ )	Letter from Axsome to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 01/06/2025)